ACAD

ACADIA Pharmaceuticals Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$22.20

Market Cap

$3.78B

Beta

0.83

P/E

9.9

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+11.87%

EPS Growth (YoY)+68.38%

Revenue CAGR 3Y+27.48%

P/E Ratio9.9

PEG Ratio0.14

FCF Yield+2.78%

Debt / Equity0.04

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for ACAD.